Product Code: TMRGL26612
The report provides revenue of the global urinary incontinence treatment devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global urinary incontinence treatment devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the urinary incontinence treatment devices market.
The report delves into the competitive landscape of the global urinary incontinence treatment devices market. Key players operating in the global urinary incontinence treatment devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global urinary incontinence treatment devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Urinary Incontinence Treatment Devices Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Prevalence of Urinary Incontinence, by Key Region
- 5.3. Regulatory & Reimbursement Scenario, by Country/Region
- 5.4. COVID-19 Impact Analysis
6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Urethral Slings
- 6.3.1.1. Female Slings
- 6.3.1.2. Male Slings
- 6.3.2. Electrical Stimulation Devices
- 6.3.2.1. Implantable
- 6.3.2.2. Non-implantable
- 6.3.3. Artificial Urinary Sphincters
- 6.3.4. Catheters
- 6.4. Market Attractiveness Analysis, by Product
7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 7.3.1. Stress Urinary Incontinence
- 7.3.2. Urge Urinary Incontinence
- 7.3.3. Mixed Incontinence
- 7.3.4. Overflow Incontinence
- 7.4. Market Attractiveness Analysis, by Incontinence Type
8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Ambulatory Surgery Centers
- 8.3.3. Clinics
- 8.3.4. Home Use
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Urethral Slings
- 10.2.1.1. Female Slings
- 10.2.1.2. Male Slings
- 10.2.2. Electrical Stimulation Devices
- 10.2.2.1. Implantable
- 10.2.2.2. Non-implantable
- 10.2.3. Artificial Urinary Sphincters
- 10.2.4. Catheters
- 10.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 10.3.1. Stress Urinary Incontinence
- 10.3.2. Urge Urinary Incontinence
- 10.3.3. Mixed Incontinence
- 10.3.4. Overflow Incontinence
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Ambulatory Surgery Centers
- 10.4.3. Clinics
- 10.4.4. Home Use
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Incontinence Type
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Urethral Slings
- 11.2.1.1. Female Slings
- 11.2.1.2. Male Slings
- 11.2.2. Electrical Stimulation Devices
- 11.2.2.1. Implantable
- 11.2.2.2. Non-implantable
- 11.2.3. Artificial Urinary Sphincters
- 11.2.4. Catheters
- 11.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 11.3.1. Stress Urinary Incontinence
- 11.3.2. Urge Urinary Incontinence
- 11.3.3. Mixed Incontinence
- 11.3.4. Overflow Incontinence
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Ambulatory Surgery Centers
- 11.4.3. Clinics
- 11.4.4. Home Use
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Incontinence Type
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Urethral Slings
- 12.2.1.1. Female Slings
- 12.2.1.2. Male Slings
- 12.2.2. Electrical Stimulation Devices
- 12.2.2.1. Implantable
- 12.2.2.2. Non-implantable
- 12.2.3. Artificial Urinary Sphincters
- 12.2.4. Catheters
- 12.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 12.3.1. Stress Urinary Incontinence
- 12.3.2. Urge Urinary Incontinence
- 12.3.3. Mixed Incontinence
- 12.3.4. Overflow Incontinence
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Ambulatory Surgery Centers
- 12.4.3. Clinics
- 12.4.4. Home Use
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Incontinence Type
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Urethral Slings
- 13.2.1.1. Female Slings
- 13.2.1.2. Male Slings
- 13.2.2. Electrical Stimulation Devices
- 13.2.2.1. Implantable
- 13.2.2.2. Non-implantable
- 13.2.3. Artificial Urinary Sphincters
- 13.2.4. Catheters
- 13.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 13.3.1. Stress Urinary Incontinence
- 13.3.2. Urge Urinary Incontinence
- 13.3.3. Mixed Incontinence
- 13.3.4. Overflow Incontinence
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Ambulatory Surgery Centers
- 13.4.3. Clinics
- 13.4.4. Home Use
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Incontinence Type
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Urethral Slings
- 14.2.1.1. Female Slings
- 14.2.1.2. Male Slings
- 14.2.2. Electrical Stimulation Devices
- 14.2.2.1. Implantable
- 14.2.2.2. Non-implantable
- 14.2.3. Artificial Urinary Sphincters
- 14.2.4. Catheters
- 14.3. Market Value Forecast, by Incontinence Type, 2017-2031
- 14.3.1. Stress Urinary Incontinence
- 14.3.2. Urge Urinary Incontinence
- 14.3.3. Mixed Incontinence
- 14.3.4. Overflow Incontinence
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Ambulatory Surgery Centers
- 14.4.3. Clinics
- 14.4.4. Home Use
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Incontinence Type
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. C. R. Bard, Inc. (Becton, Dickinson and Company)
- 15.3.1.1. Company Description
- 15.3.1.2. Business Overview
- 15.3.1.3. Financial Overview
- 15.3.1.4. Strategic Overview
- 15.3.1.5. SWOT Analysis
- 15.3.2. Coloplast Group
- 15.3.2.1. Company Description
- 15.3.2.2. Business Overview
- 15.3.2.3. Financial Overview
- 15.3.2.4. Strategic Overview
- 15.3.2.5. SWOT Analysis
- 15.3.3. Promedon Group
- 15.3.3.1. Company Description
- 15.3.3.2. Business Overview
- 15.3.3.3. Financial Overview
- 15.3.3.4. Strategic Overview
- 15.3.3.5. SWOT Analysis
- 15.3.4. A.M.I. GmbH
- 15.3.4.1. Company Description
- 15.3.4.2. Business Overview
- 15.3.4.3. Financial Overview
- 15.3.4.4. Strategic Overview
- 15.3.4.5. SWOT Analysis
- 15.3.5. Ethicon US, LLC. (Johnson & Johnson)
- 15.3.5.1. Company Description
- 15.3.5.2. Business Overview
- 15.3.5.3. Financial Overview
- 15.3.5.4. Strategic Overview
- 15.3.5.5. SWOT Analysis
- 15.3.6. ZSI Surgical Implants S.R.L.
- 15.3.6.1. Company Description
- 15.3.6.2. Business Overview
- 15.3.6.3. Financial Overview
- 15.3.6.4. Strategic Overview
- 15.3.6.5. SWOT Analysis
- 15.3.7. Medtronic plc
- 15.3.7.1. Company Description
- 15.3.7.2. Business Overview
- 15.3.7.3. Financial Overview
- 15.3.7.4. Strategic Overview
- 15.3.7.5. SWOT Analysis
- 15.3.8. InControl Medical LLC
- 15.3.8.1. Company Description
- 15.3.8.2. Business Overview
- 15.3.8.3. Financial Overview
- 15.3.8.4. Strategic Overview
- 15.3.8.5. SWOT Analysis
- 15.3.9. Hollister Incorporated
- 15.3.9.1. Company Description
- 15.3.9.2. Business Overview
- 15.3.9.3. Financial Overview
- 15.3.9.4. Strategic Overview
- 15.3.9.5. SWOT Analysis
- 15.3.10. Atlantic Therapeutics Group Ltd.
- 15.3.10.1. Company Description
- 15.3.10.2. Business Overview
- 15.3.10.3. Financial Overview
- 15.3.10.4. Strategic Overview
- 15.3.10.5. SWOT Analysis
- 15.3.11. B. Braun Melsungen AG
- 15.3.11.1. Company Description
- 15.3.11.2. Business Overview
- 15.3.11.3. Financial Overview
- 15.3.11.4. Strategic Overview
- 15.3.11.5. SWOT Analysis
- 15.3.12. Teleflex Incorporated
- 15.3.12.1. Company Description
- 15.3.12.2. Business Overview
- 15.3.12.3. Financial Overview
- 15.3.12.4. Strategic Overview
- 15.3.12.5. SWOT Analysis